Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- SSP Plans to Develop OTC Drugs Using Western Herbs
December 11, 2006
- IHOKEN FORUM 2006
December 11, 2006
- SURVEY of Korosho
December 11, 2006
- REGULATORY NEWS IN BRIEF
December 11, 2006
- Addition of Guidant Enhances Abbott Vascular's Global Presence: Mr D. C. Bryant
December 11, 2006
- TOPIC an article
December 11, 2006
- Chugai Announces Strategic Goals for 2010
December 11, 2006
- Teijin to Promote "R&D Fully Integrated with Management": Mr Yamagishi
December 11, 2006
- Banyu Begins Detailing Preminent, a Combination Drug for Hypertension
December 11, 2006
- Nippon Shinyaku Licenses Pharmion's Vidaza
December 4, 2006
- R&D NEWS IN BRIEF -2-
December 4, 2006
- Sales of Spiriva Could Reach \20 Bil. in the Near Future: NBI
December 4, 2006
- Seminar
December 4, 2006
- Chugai, GSK Working to Ensure Stable Supply of Anti-flu Drugs
December 4, 2006
- MEDICAL DEVICE NEWS IN BRIEF
December 4, 2006
- BUSINESS NEWS IN BRIEF
December 4, 2006
- OPINION
December 4, 2006
- Taiyo Yakuhin to Do More Business with Multiregional Wholesalers
December 4, 2006
- JMA Confirms Opposition to Insurance Deductible System, Flat Sum Payment for Elderly
December 4, 2006
- 4 Major GE Houses Report Growth in Semiannual Sales, Profits
December 4, 2006
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…